A detailed history of Wellington Management Group LLP transactions in Astrazeneca PLC stock. As of the latest transaction made, Wellington Management Group LLP holds 37,247,083 shares of AZN stock, worth $2.44 Billion. This represents 0.52% of its overall portfolio holdings.

Number of Shares
37,247,083
Previous 40,569,917 8.19%
Holding current value
$2.44 Billion
Previous $3.16 Billion 8.27%
% of portfolio
0.52%
Previous 0.58%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$76.67 - $87.62 $255 Million - $291 Million
-3,322,834 Reduced 8.19%
37,247,083 $2.9 Billion
Q2 2024

Aug 13, 2024

SELL
$66.81 - $80.83 $571 Million - $691 Million
-8,551,944 Reduced 17.41%
40,569,917 $3.16 Billion
Q1 2024

May 15, 2024

BUY
$61.03 - $69.57 $3 Billion - $3.42 Billion
49,121,861 New
49,121,861 $3.33 Billion
Q4 2023

Feb 12, 2024

BUY
$61.89 - $69.28 $3.06 Billion - $3.43 Billion
49,444,180 New
49,444,180 $3.33 Billion
Q3 2023

Nov 14, 2023

BUY
$64.85 - $71.7 $23.2 Million - $25.7 Million
358,399 Added 0.73%
49,492,814 $3.35 Billion
Q2 2023

Aug 14, 2023

SELL
$69.91 - $75.81 $246 Million - $267 Million
-3,520,087 Reduced 6.69%
49,134,415 $3.52 Billion
Q1 2023

May 12, 2023

SELL
$63.15 - $71.6 $123 Million - $140 Million
-1,951,550 Reduced 3.57%
52,654,502 $3.65 Billion
Q4 2022

Feb 13, 2023

BUY
$54.21 - $70.44 $128 Million - $166 Million
2,359,136 Added 4.52%
54,606,052 $3.7 Billion
Q3 2022

Nov 14, 2022

BUY
$53.02 - $135.75 $209 Million - $536 Million
3,948,994 Added 8.18%
52,246,916 $2.87 Billion
Q2 2022

Aug 15, 2022

BUY
$59.26 - $71.14 $95.2 Million - $114 Million
1,606,887 Added 3.44%
48,297,922 $3.19 Billion
Q1 2022

May 16, 2022

SELL
$55.72 - $67.12 $23.1 Million - $27.8 Million
-414,016 Reduced 0.88%
46,691,035 $3.1 Billion
Q4 2021

Feb 11, 2022

SELL
$54.02 - $63.83 $326 Million - $386 Million
-6,040,513 Reduced 11.37%
47,105,051 $2.74 Billion
Q3 2021

Nov 15, 2021

BUY
$55.56 - $60.79 $251 Million - $275 Million
4,526,346 Added 9.31%
53,145,564 $3.19 Billion
Q2 2021

Aug 16, 2021

SELL
$48.42 - $60.18 $31.1 Million - $38.6 Million
-642,215 Reduced 1.3%
48,619,218 $2.91 Billion
Q1 2021

May 17, 2021

BUY
$47.16 - $54.44 $31.8 Million - $36.7 Million
673,447 Added 1.39%
49,261,433 $2.45 Billion
Q4 2020

Feb 12, 2021

SELL
$48.52 - $58.02 $170 Million - $203 Million
-3,505,697 Reduced 6.73%
48,587,986 $2.43 Billion
Q3 2020

Nov 16, 2020

SELL
$53.07 - $61.1 $130 Million - $150 Million
-2,450,834 Reduced 4.49%
52,093,683 $2.85 Billion
Q2 2020

Aug 14, 2020

SELL
$43.1 - $55.31 $552 Million - $709 Million
-12,813,874 Reduced 19.02%
54,544,517 $2.88 Billion
Q1 2020

May 14, 2020

BUY
$37.79 - $51.33 $81.8 Million - $111 Million
2,163,500 Added 3.32%
67,358,391 $3.01 Billion
Q4 2019

Feb 11, 2020

BUY
$42.46 - $50.46 $2.77 Billion - $3.29 Billion
65,194,891 New
65,194,891 $3.25 Billion

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $203B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Wellington Management Group LLP Portfolio

Follow Wellington Management Group LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.